PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of Zr-89-Cetuximab

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)249-254
JournalJournal of Nuclear Medicine
Volume56
Issue number2
DOIs
Publication statusPublished - 2015

Cite this

@article{ba37ba9d94a24bb6a7c4353aceef4266,
title = "PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of Zr-89-Cetuximab",
author = "N. Makris and R. Boellaard and {van Lingen}, A. and A.A. Lammertsma and {van Dongen}, G.A.M.S. and H.M. Verheul and {van der Houven van Oordt}, C.W. and M.C. Huisman",
year = "2015",
doi = "10.2967/jnumed.114.147819",
language = "Undefined/Unknown",
volume = "56",
pages = "249--254",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "2",

}

TY - JOUR

T1 - PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of Zr-89-Cetuximab

AU - Makris, N.

AU - Boellaard, R.

AU - van Lingen, A.

AU - Lammertsma, A.A.

AU - van Dongen, G.A.M.S.

AU - Verheul, H.M.

AU - van der Houven van Oordt, C.W.

AU - Huisman, M.C.

PY - 2015

Y1 - 2015

U2 - 10.2967/jnumed.114.147819

DO - 10.2967/jnumed.114.147819

M3 - Article

VL - 56

SP - 249

EP - 254

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 2

ER -